ClinicalTrials.Veeva

Menu

Severe Lung Disease in Childhood

O

Odense University Hospital

Status

Enrolling

Conditions

Lung Disease Chronic

Treatments

Diagnostic Test: lung function measurements

Study type

Observational

Funder types

Other

Identifiers

NCT06455800
HCA-Lung

Details and patient eligibility

About

Only little information exists about the long term consequences of having severe lung disease in childhood. The patient population is heterogenous and the prognostic markers are few.

This observational study will investigate which parameters that can be used to predict the outcome of having severe lung disease in childhood.

Full description

All patients aged 0-18 years at the HCA Childrens Hospital with a severe lung disease will prospectively be registered in a database.

At a yearly follow up, data from the patient record will be registered. Informed consent from the patients and/or their parents will be obtained. Registered data will include height, weight, results of lung function tests and imaging diagnostics.

The study will provide knowledge of the prognosis of different lung diseases and how to monitor lung function in children.

Enrollment

200 estimated patients

Sex

All

Ages

1 day to 18 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: severe lung disease -

Exclusion Criteria: no informed consent

Trial contacts and locations

1

Loading...

Central trial contact

Josefine Gradman, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems